Hyperforin halogenated derivatives, the use thereof and formulations containing them
US7057078B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2003 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | Apr 15, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C49/713
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Hyperforin and adhyperforin halogenated derivatives of general formula (I) in which X, R and R1 have the meanings as defined in the disclosure, the process for the preparation thereof and the use thereof in the pharmaceutical and/or nutritional field, in particular in the treatment of depression, and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.